| 1. | keiththewolf94 | |
| 2. | mokakaippnxxtsz7 | |
| 3. | coskot | |
| 4. | phmolter | |
| 5. | mjones5944 |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | phmolter 02/05/2018 Stifel Nicolaus cuts PT to $20 from $25 |
| 2. | keiththewolf94 09/28/2018 Receives FDA orphan drug designation for Relacorilant |
| 3. | keiththewolf94 02/05/2018 hoping $16 holds |
| 4. | mokakaippnxxtsz7 02/26/2018 Corcept Therapeutics Announces 2017 Financial Results and Positive Interim Results of Relacorilant Phase 2 Trial |
| 5. | mjones5944 02/05/2018 ouch! {Image} |
| 6. | mjones5944 02/02/2018 Corcept Therapeutics Announces Fourth Quarter and Full-Year 2017 Preliminary Selected Financial Results; Provides 2018 Revenue Guidance |
| 7. | keiththewolf94 02/22/2018 Reports Relacorilant Phase 2 Trial interim results |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Corcept Therapeutics Incorporated
- CORT
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.